During the past decade, Hospital General Universitario Reina Sofía conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General Universitario Reina Sofía" #1 sponsor was "Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA" with 4 trials, followed by "Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias" with 2 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 2 trials sponsored, "Hospital General Universitario Reina Sofía de Murcia" with 2 trials sponsored and "Kissei Pharmaceutical Co., Ltd." with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario Reina Sofía" #1 collaborator was "Fondo de Investigacion Sanitaria" with 2 trials as a collaborator, "Hospital Universitario 12 de Octubre" with 2 trials as a collaborator, "Hospital Universitario Reina Sofia de Cordoba" with 2 trials as a collaborator, "Effice Servicios Para la Investigacion S.L." with 1 trials as a collaborator and "Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General Universitario Reina Sofía" are "Colorectal Cancer" (3 trials), "Critical Illness" (2 trials), "Endometriosis" (2 trials), "HIV Infections" (2 trials) and "Leukemia, Myelocytic, Acute" (2 trials). Many other conditions were trialed in "Hospital General Universitario Reina Sofía" in a lesser frequency.

Most popular intervention types in "Hospital General Universitario Reina Sofía" are "Drug" (19 trials), "Other" (6 trials), "Procedure" (4 trials), "Dietary Supplement" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "200 mg linzagolix tablet" (2 trials), "75 mg linzagolix tablet" (2 trials), "Add-back capsule (E2 1 mg / NETA 0.5 mg)" (2 trials), "Ara-C" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General Universitario Reina Sofía" are 30 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital General Universitario Reina Sofía". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Hospital General Universitario Reina Sofía, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General Universitario Reina Sofía, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".